GlassScriptPhysician profile
Paul Christopher Lafata
NPI 1790785947
$10,011.94
in general payments reported to CMS, 2019-2025
26 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,918 · 2020: $346 · 2021: $1,704 · 2022: $2,120 · 2023: $668 · 2024: $1,230 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768 · Entertainment: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.84 |
| Entertainment | $156.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,696.11 | 2019-2024 | Ortholoc 3di, Prophecy |
| Novus Surgical Solutions LLC | $1,385.60 | 2022 | |
| Organogenesis INC. | $1,214.13 | 2019-2025 | Puraply, Puraply Wound Matrix, Puraforce |
| Medical Device Business Services, INC. | $1,154.21 | 2019 | |
| Treace Medical Concepts, INC. | $929.94 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $809.51 | 2019-2024 | Nextremity General Instrument, Tapestry, A.L.P.S. |
| Smith+Nephew, INC. | $677.08 | 2019-2025 | Stravix Pl, Grafix Pl, Stravix |
| Aroa Biosurgery Incorporated | $242.86 | 2023-2024 | |
| Integra Lifesciences Corporation | $231.84 | 2020-2022 | |
| Depuy Synthes Sales INC. | $230.11 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $169.00 | 2022-2023 | |
| Biocomposites INC | $150.00 | 2024 | |
| Alexion Pharmaceuticals, INC. | $134.99 | 2024 | |
| Paratek Pharmaceuticals, INC. | $131.45 | 2024-2025 | Nuzyra |
| Abbvie INC. | $125.00 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $112.50 | 2019 | |
| Axogen | $110.80 | 2019 | |
| Tei Medical INC. | $97.95 | 2019 | |
| Kuros Biosciences USA, INC | $93.67 | 2024 | Magnetos |
| Anika Therapeutics, INC. | $85.14 | 2024 | Tactoset, X-Twist, Drawtight |
| Medartis INC. | $64.55 | 2024 | Aptus |
| Trilliant Surgical LLC. | $51.73 | 2020 | |
| Lifenet Health | $51.58 | 2023 | |
| Next Science LLC | $31.08 | 2023 | Xperience, Surgx, Blastx |
| Kowa Pharmaceuticals America, INC. | $16.09 | 2023 | Seglentis |
| Convatec INC. | $15.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lafata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.